Shandong Xinhua Pharmaceutical Company Limited XIN.F Stock
Shandong Xinhua Pharmaceutical Company Limited Price Chart
Shandong Xinhua Pharmaceutical Company Limited XIN.F Financial and Trading Overview
Contents
- Shandong Xinhua Pharmaceutical Company Limited Price Chart
- Shandong Xinhua Pharmaceutical Company Limited XIN.F Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Shandong Xinhua Pharmaceutical Company Limited
- Q&A For Shandong Xinhua Pharmaceutical Company Limited Stock
Shandong Xinhua Pharmaceutical Company Limited stock price | 0.63 EUR |
Previous Close | 0.7 EUR |
Open | 0.7 EUR |
Bid | 0.7 EUR x 1000000 |
Ask | 0.76 EUR x 1000000 |
Day's Range | 0.7 - 0.7 EUR |
52 Week Range | 0.46 - 1.71 EUR |
Volume | 11 EUR |
Avg. Volume | 0 EUR |
Market Cap | 1.54B EUR |
Beta (5Y Monthly) | 0.114176 |
PE Ratio (TTM) | 7.777777 |
EPS (TTM) | 0.09 EUR |
Forward Dividend & Yield | 0.02 (3.18%) |
Ex-Dividend Date | July 15, 2022 |
1y Target Est | N/A |
XIN.F Valuation Measures
Enterprise Value | 1.17B EUR |
Trailing P/E | 7.777777 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.18581492 |
Price/Book (mrq) | 0.10910224 |
Enterprise Value/Revenue | 0.141 |
Enterprise Value/EBITDA | 1.157 |
Trading Information
Shandong Xinhua Pharmaceutical Company Limited Stock Price History
Beta (5Y Monthly) | 0.114176 |
52-Week Change | 8.52% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1.71 EUR |
52 Week Low | 0.46 EUR |
50-Day Moving Average | 0.72 EUR |
200-Day Moving Average | 0.72 EUR |
XIN.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 195M |
Float | 415.38M |
Short Ratio | N/A |
% Held by Insiders | 10.68% |
% Held by Institutions | 1.33% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.2 |
Trailing Annual Dividend Yield | 28.57% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.2292 |
Last Split Factor | 13:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 5.46% |
Operating Margin (ttm) | 6.20% |
Gross Margin | 27.86% |
EBITDA Margin | 12.17% |
Management Effectiveness
Return on Assets (ttm) | 4.11% |
Return on Equity (ttm) | 10.95% |
Income Statement
Revenue (ttm) | 8.31B EUR |
Revenue Per Share (ttm) | 12.48 EUR |
Quarterly Revenue Growth (yoy) | 44.10% |
Gross Profit (ttm) | N/A |
EBITDA | 1.01B EUR |
Net Income Avi to Common (ttm) | 454.29M EUR |
Diluted EPS (ttm) | 0.09 |
Quarterly Earnings Growth (yoy) | 39.70% |
Balance Sheet
Total Cash (mrq) | 863.7M EUR |
Total Cash Per Share (mrq) | 1.28 EUR |
Total Debt (mrq) | 1.34B EUR |
Total Debt/Equity (mrq) | 29.4 EUR |
Current Ratio (mrq) | 1.468 |
Book Value Per Share (mrq) | 6.416 |
Cash Flow Statement
Operating Cash Flow (ttm) | 592.21M EUR |
Levered Free Cash Flow (ttm) | 560.95M EUR |
Profile of Shandong Xinhua Pharmaceutical Company Limited
Country | Germany |
State | N/A |
City | Zibo |
Address | Chemical Industry Area |
ZIP | 255005 |
Phone | 86 53 3216 6666 |
Website | https://www.xhzy.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products. It operates through Chemical bulk drugs, Preparations, and Chemical intermediates and Others segments. The company offers active pharmaceutical ingredients, pharmaceutical preparations, and chemical products, such as antipyretic analgesics; drugs for cardiovascular and cerebrovascular diseases; anti-infectives; drugs for diseases related to the central nervous system; and other drugs under the Xinhua brand. It also provides prepared Chinese herbal medicine decoction, traditional Chinese medicines, chemical preparations, antibiotics, biochemical medicines, chemical bulk drugs, anesthetics, anti-psychotic drugs, pharmaceutical precursor chemicals, protein assimilation preparations, peptide hormones, medical toxic drugs, etc.; and chemical raw materials, such as dimethyl sulfate, isobutylbenzene, 1,8-diazabicyclo, undec-7-ene, and tetramethylguanidine. In addition, the company offers materials and intermediates, powders for injection and tablets; tablets, hard capsules, granules, and dry suspension; imports and exports goods and technologies; designs medical projects; and health products research and development activities. Further, it engages in the certification business; electrical equipment engineering; and installation and testing of chemical equipment and electrical equipment, as well as the sale of mechanical, hardware, and electrical equipment. Additionally, the company produces and sells high-end steroid system APIs and intermediates; and provides internet data, internet sells, and internet information services for pharmaceuticals and medical devices, etc. It operates in the People's Republic of China, the Americas, Europe, and internationally. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.
Q&A For Shandong Xinhua Pharmaceutical Company Limited Stock
What is a current XIN.F stock price?
Shandong Xinhua Pharmaceutical Company Limited XIN.F stock price today per share is 0.63 EUR.
How to purchase Shandong Xinhua Pharmaceutical Company Limited stock?
You can buy XIN.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shandong Xinhua Pharmaceutical Company Limited?
The stock symbol or ticker of Shandong Xinhua Pharmaceutical Company Limited is XIN.F.
Which industry does the Shandong Xinhua Pharmaceutical Company Limited company belong to?
The Shandong Xinhua Pharmaceutical Company Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Shandong Xinhua Pharmaceutical Company Limited have in circulation?
The max supply of Shandong Xinhua Pharmaceutical Company Limited shares is 1.76B.
What is Shandong Xinhua Pharmaceutical Company Limited Price to Earnings Ratio (PE Ratio)?
Shandong Xinhua Pharmaceutical Company Limited PE Ratio is 6.99999950 now.
What was Shandong Xinhua Pharmaceutical Company Limited earnings per share over the trailing 12 months (TTM)?
Shandong Xinhua Pharmaceutical Company Limited EPS is 0.09 EUR over the trailing 12 months.
Which sector does the Shandong Xinhua Pharmaceutical Company Limited company belong to?
The Shandong Xinhua Pharmaceutical Company Limited sector is Healthcare.